ArticleEuropean journal of epidemiology2020
The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
Article in European journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Trial
- Antibody-Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers.Journal of the American Chemical Society · 2022Article
- COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.PloS one · 2022Article
- Aggressive containment, suppression, and mitigation of covid-19: lessons learnt from eight countries.BMJ (Clinical research ed.) · 2021Article
- Evaluation of the performance of SARS--CoV--2 antibody assays for a longitudinal population-based study of COVID--19 spread in St. Petersburg, Russia.Journal of medical virology · 2021Article
- Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study.Scientific reports · 2021Article
- Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.Research square · 2021Article
- Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg.Journal of clinical medicine · 2020Article
- Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave.Journal of epidemiology and community health · 2020Article
- Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples.Clinica chimica acta; international journal of clinical chemistry · 2020Article
- Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2020Article
- SARS-CoV-2 pandemic: An overview.Advances in biological regulation · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.